Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CCL19 Antikörper (Internal Region)

CCL19 Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7187302
  • Target Alle CCL19 Antikörper anzeigen
    CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))
    Bindungsspezifität
    • 16
    • 6
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Internal Region
    Reaktivität
    • 52
    • 19
    • 5
    • 2
    Human
    Wirt
    • 44
    • 14
    • 1
    Kaninchen
    Klonalität
    • 42
    • 17
    Polyklonal
    Konjugat
    • 28
    • 10
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CCL19 Antikörper ist unkonjugiert
    Applikation
    • 47
    • 27
    • 24
    • 13
    • 13
    • 6
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    Immunohistochemistry (IHC), ELISA
    Kreuzreaktivität
    Human
    Aufreinigung
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
    Immunogen
    Synthesized peptide derived from the Internal region of Human MIP-3beta.
    Isotyp
    IgG
    Top Product
    Discover our top product CCL19 Primärantikörper
  • Applikationshinweise
    IHC:1:100-1:300, ELISA:1:40000,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))
    Andere Bezeichnung
    CCL19 (CCL19 Produkte)
    Synonyme
    CKb11 antikoerper, ELC antikoerper, MIP-3b antikoerper, MIP3B antikoerper, SCYA19 antikoerper, CCL19 antikoerper, Scya19 antikoerper, exodus-3 antikoerper, C-C motif chemokine ligand 19 antikoerper, chemokine (C-C motif) ligand 19 antikoerper, CCL19 antikoerper, ccl19 antikoerper, Ccl19 antikoerper
    Hintergrund
    Beta chemokine exodus 3 antibody, Beta-chemokine exodus-3 antibody, C C chemokine ligand 19 antibody, C-C motif chemokine 19 antibody, CC chemokine ligand 19 antibody, CCL 19 antibody, CCL19 antibody, CCL19_HUMAN antibody, Chemokine (C C motif) ligand 19 antibody, Chemokine (CC motif) ligand 19 antibody, Chemokine C C Motif Ligand 19 antibody, Chemokine CC Motif Ligand 19 antibody, CK beta 11 antibody, CK beta-11 antibody, CKb 11 antibody, CKb11 antibody, EBI 1 ligand chemokine antibody, EBI1 ligand chemokine antibody, ELC antibody, Epstein-Barr virus-induced molecule 1 ligand chemokine antibody, Exodus 3 antibody, Exodus3 antibody, Macrophage inflammatory protein 3 beta antibody, MGC34433 antibody, MIP 3 beta antibody, MIP 3B antibody, MIP-3-beta antibody, MIP-3b antibody, MIP3 beta antibody, MIP3B antibody, OTTHUMP00000000531 antibody, SCYA 19 antibody, SCYA19 antibody, Small inducible cytokine A19 antibody, Small inducible cytokine subfamily A (Cys Cys) member 1 antibody, Small-inducible cytokine A19 antibody
    UniProt
    Q99731
    Pathways
    Positive Regulation of Immune Effector Process
Sie sind hier: